The largest database of trusted experimental protocols

Rab0904

Manufactured by Merck Group
Sourced in United States

RAB0904 is a laboratory equipment product manufactured by Merck Group. It is designed for use in scientific research and analysis applications. The core function of RAB0904 is to facilitate sample preparation and handling processes in a laboratory setting.

Automatically generated - may contain errors

3 protocols using rab0904

1

Lipid and Inflammatory Biomarker Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Triglycerides and total cholesterol concentrations were determined by enzymatic colorimetric methods using available commercial kits (Wiener lab Group, Argentina). The high-density lipoprotein cholesterol (HDLc) was determined after precipitation of very low-density lipoprotein (VLDL) and low-density lipoprotein (LDLc) with polyanions (dextran sulphate and magnesium chloride). LDL-cholesterol concentration was determined by a two-step homogeneous assay without precipitation. Free fatty acids were determined using available commercial kits (ab65341, Abcam, USA).
Circulating tumor necrosis factor-α (TNF-α) (RAB0479), interleukin-1β (IL-1β) (RAB0277), insulin (RAB0904) (all from SIGMA Aldrich, St. Louis, MO, USA), leptin (ab100773), and adiponectin (ab108784) (Abcam, USA) were performed using commercially available kits according to the manufacturer′s instructions.
Blood glucose concentrations were measured using a glucose meter (Roche Diagnostics GmbH, Mannheim, Germany). The HOMA-IR (Homeostasis model assessment of insulin resistance) index was calculated as [fasting glucose (mg/dl) × fasting insulin (ng/ml)/405] to assess insulin resistance [38 (link)].
+ Open protocol
+ Expand
2

Serum and Pancreatic Insulin Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were centrifuged at 4,000 g for 30 min to collect blood serum. The serum insulin level was measured using a rat insulin enzyme-linked immunosorbent assay (ELISA) kit, following the manufacturer's instructions (Cat. Number # EZRMI-13 K, Merck Millipore, USA).
For determination of pancreatic insulin content, pancreatic tissues were washed with phosphate buffered saline (PBS) and homogenized with acid ethanol (0.18 M HCL in 70% ethanol), overnight at −20 °C. The homogenates were centrifuged at 14,000 g, 4 °C for 30 min to obtain supernatant for determining the insulin content. A rat insulin ELISA kit was used, following the manufacturer's instructions (Cat. Number # RAB0904, Sigma Aldrich, USA).
+ Open protocol
+ Expand
3

Oral Glucose Tolerance and Insulin Resistance Assessment in Diabetic Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight weeks after arrival, all rats underwent an oral glucose tolerance test (OGTT) to confirm glucose intolerance in diabetic rats. Animals were fasted overnight and then given an oral dose of glucose solution (BioShop Canada Inc.) at 1 g/kg via gavage. Blood glucose was measured over 2 h, prior to gavage and at 30-min intervals post-glucose consumption.
Nine weeks after arrival, all rats underwent an insulin tolerance test (ITT) to assess insulin resistance in diabetic rats. Animals were fasted for 6 h and injected IP with insulin solution (0.75 U/kg, Sigma-Aldrich, I9278). Blood glucose was measured prior to injection, at 15-min intervals post-injection for the first hour, and 30-min intervals for the second hour.
One-month post-diabetes (11 weeks after arrival), blood plasma insulin levels were tested in all rats to confirm insulin resistance in diabetic rats. Animals were fasted overnight, and blood from the saphenous vein was collected in lithium-heparin tubes. Tubes were centrifuged for 8 min at 8,000 rcf and blood plasma was separated from the samples. A rat insulin ELISA kit (Sigma-Aldrich, RAB0904) was used to determine insulin levels in the plasma samples. A homeostatic model assessment of insulin resistance (HOMA-IR) was then calculated as Insulin (uIUmL) x Fasting Glucose (mmolL)  22.5  to assess insulin resistance (14 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!